Ignite Creation Date:
2025-12-26 @ 4:00 PM
Ignite Modification Date:
2026-03-11 @ 11:31 AM
Study NCT ID:
NCT01984606
Status:
WITHDRAWN
Last Update Posted:
2014-10-27
First Post:
2013-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetes Mellitus, Type 2 | View |
Keywords: